Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1980 Feb 1;151(2):275–288. doi: 10.1084/jem.151.2.275

Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection

PMCID: PMC2185790  PMID: 6766174

Abstract

The effects of monospecific antibodies to the viral glycoprotein with hemagglutinating and neuraminidase activity (HN) and the viral glycoprotein with membrane-fusing activity (F) of the paramyxovirus simian virus 5 (SV5) on the spread of infection in two cell types have been investigated. In CV-1 cells, infection can spread by either released progeny virus adsorbing to and infecting other cells, or by fusion of an infected cell with an adjacent cell as a result of the cell-fusing activity of the F glycoprotein. In these cells, antibodies specific for the HN glycoprotein prevented the dissemination of infection by released infectious virus, but spread by cell fusion was not inhibited. Antibodies to the F glycoprotein completely prevented the spread of infection in these cells. In Madin-Darby bovine kidney cells, which are relatively resistant to SV5-induced fusion, antibodies to either the HN or F glycoproteins were capable of preventing the dissemination of infection. These results indicate that effective immunological prevention of the spread of paramyxovirus infection requires the presence of antibodies that inactivate the F glycoprotein. This requirement for anti-F antibodies has obvious implications for the design of effective paramyxovirus vaccines and provides an explanation for previous failures of formalin-inactivated paramyxovirus vaccines as well as additional insight into the possible immunopathological mechanisms involved in the atypical and severe infections that have occurred in individuals who received inactivated paramyxovirus vaccines and were subsequently infected by the virus.

Full Text

The Full Text of this article is available as a PDF (2.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellanti J. A. Biologic significance of the secretory A immunoglobulins. Pediatrics. 1971 Nov;48(5):715–729. [PubMed] [Google Scholar]
  2. Blandford G. Arthus reaction and pneumonia. Br Med J. 1970 Mar 21;1(5698):758–759. doi: 10.1136/bmj.1.5698.758-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brentjens J. R., O'Connell D. W., Pawlowski I. B., Hsu K. C., Andres G. A. Experimental immune complex disease of the lung. The pathogenesis of a laboratory model resembling certain human interstitial lung diseases. J Exp Med. 1974 Jul 1;140(1):105–125. doi: 10.1084/jem.140.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buser F. Side reaction to measles vaccination suggesting the Arthus phenomenon. N Engl J Med. 1967 Aug 3;277(5):250–251. doi: 10.1056/NEJM196708032770507. [DOI] [PubMed] [Google Scholar]
  5. CHOPPIN P. W. MULTIPLICATION OF A MYXOVIRUS (SV5) WITH MINIMAL CYTOPATHIC EFFECTS AND WITHOUT INTERFERENCE. Virology. 1964 Jun;23:224–233. doi: 10.1016/0042-6822(64)90286-7. [DOI] [PubMed] [Google Scholar]
  6. Chanock R. M. Control of acute mycoplasmal and viral respiratory tract disease. Science. 1970 Jul 17;169(3942):248–256. doi: 10.1126/science.169.3942.248. [DOI] [PubMed] [Google Scholar]
  7. Chanock R. M., Kapikian A. Z., Mills J., Kim H. W., Parrott R. H. Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health. 1970 Sep;21(3):347–355. doi: 10.1080/00039896.1970.10667249. [DOI] [PubMed] [Google Scholar]
  8. Chen C., Compans R. W., Choppin P. W. Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities. J Gen Virol. 1971 Apr;11(1):53–58. doi: 10.1099/0022-1317-11-1-53. [DOI] [PubMed] [Google Scholar]
  9. Chin J., Magoffin R. L., Shearer L. A., Schieble J. H., Lennette E. H. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969 Apr;89(4):449–463. doi: 10.1093/oxfordjournals.aje.a120957. [DOI] [PubMed] [Google Scholar]
  10. Compans R. W., Holmes K. V., Dales S., Choppin P. W. An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. Virology. 1966 Nov;30(3):411–426. doi: 10.1016/0042-6822(66)90119-x. [DOI] [PubMed] [Google Scholar]
  11. Delage G., Brochu P., Pelletier M., Jasmin G., Lapointe N. Giant-cell pneumonia caused by parainfluenza virus. J Pediatr. 1979 Mar;94(3):426–429. doi: 10.1016/s0022-3476(79)80591-0. [DOI] [PubMed] [Google Scholar]
  12. ENDERS J. F., McCARTHY K., MITUS A., CHEATHAM W. J. Isolation of measles virus at autopsy in cases of giant-cell pneumonia without rash. N Engl J Med. 1959 Oct 29;261:875–881. doi: 10.1056/NEJM195910292611801. [DOI] [PubMed] [Google Scholar]
  13. Frank G. H., Marshall R. G. Relationship of serum and nasal secretion-neutralizing antibodies in protection of calves against parainfluenza-3 virus. Am J Vet Res. 1971 Nov;32(11):1707–1713. [PubMed] [Google Scholar]
  14. Fulginiti V. A., Eller J. J., Sieber O. F., Joyner J. W., Minamitani M., Meiklejohn G. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol. 1969 Apr;89(4):435–448. doi: 10.1093/oxfordjournals.aje.a120956. [DOI] [PubMed] [Google Scholar]
  15. Graves M. C., Silver S. M., Choppin P. W. Measles virus polypeptides synthesis in infected cells. Virology. 1978 May 1;86(1):254–263. doi: 10.1016/0042-6822(78)90025-9. [DOI] [PubMed] [Google Scholar]
  16. HENLE G., DEINHARDT F., GIRARDI A. Cytolytic effects of mumps virus in tissue cultures of epithelial cells. Proc Soc Exp Biol Med. 1954 Nov;87(2):386–393. doi: 10.3181/00379727-87-21390. [DOI] [PubMed] [Google Scholar]
  17. Hall W. W., Lamb R. A., Choppin P. W. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A. 1979 Apr;76(4):2047–2051. doi: 10.1073/pnas.76.4.2047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ho C. K., Babiuk L. A. Immune mechanisms against canine distemper. I. Identification of K cell against canine distemper virus infected target cells in vitro. Immunology. 1979 May;37(1):231–239. [PMC free article] [PubMed] [Google Scholar]
  19. Holmes K. V., Choppin P. W. On the role of the response of the cell membrane in determining virus virulence. Contrasting effects of the parainfluenza virus SV5 in two cell types. J Exp Med. 1966 Sep 1;124(3):501–520. doi: 10.1084/jem.124.3.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Homma M., Ouchi M. Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J Virol. 1973 Dec;12(6):1457–1465. doi: 10.1128/jvi.12.6.1457-1465.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hsu M. C., Scheid A., Choppin P. W. Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology. 1979 Jun;95(2):476–491. doi: 10.1016/0042-6822(79)90502-6. [DOI] [PubMed] [Google Scholar]
  22. Jarvis W. R., Middleton P. J., Gelfand E. W. Parainfluenza pneumonia in severe combined immunodeficiency disease. J Pediatr. 1979 Mar;94(3):423–425. doi: 10.1016/s0022-3476(79)80590-9. [DOI] [PubMed] [Google Scholar]
  23. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
  24. Kim J. C. Immunological injury in "shipping fever" pneumonia of cattle. Vet Rec. 1977 Feb 5;100(6):109–111. doi: 10.1136/vr.100.6.109. [DOI] [PubMed] [Google Scholar]
  25. LAXDAL O. E., EVANS G. E., BRAATEN V., ROBERTSON H. E. ACUTE RESPIRATORY INFECTIONS IN CHILDREN. II. A TRIAL OF POLYVALENT VIRUS VACCINE. Can Med Assoc J. 1964 Jan 4;90:15–19. [PMC free article] [PubMed] [Google Scholar]
  26. LEVY H. B., SOBER H. A. A simple chromatographic method for preparation of gamma globulin. Proc Soc Exp Biol Med. 1960 Jan;103:250–252. doi: 10.3181/00379727-103-25476. [DOI] [PubMed] [Google Scholar]
  27. Meguro H., Kervina M., Wright P. F. Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties. J Immunol. 1979 Jun;122(6):2521–2526. [PubMed] [Google Scholar]
  28. Melewicz F. M., Shore S. L., Ades E. W., Phillips D. J. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell. J Immunol. 1977 Feb;118(2):567–573. [PubMed] [Google Scholar]
  29. Norrby E., Enders-Ruckle G., Meulen V. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis. 1975 Sep;132(3):262–269. doi: 10.1093/infdis/132.3.262. [DOI] [PubMed] [Google Scholar]
  30. Norrby E., Gollmar Y. Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun. 1975 Feb;11(2):231–239. doi: 10.1128/iai.11.2.231-239.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Norrby E., Penttinen K. Differences in antibodies to the surface components of mumps virus after immunization with formalin-inactivated and live vaccines. J Infect Dis. 1978 Nov;138(5):672–676. doi: 10.1093/infdis/138.5.672. [DOI] [PubMed] [Google Scholar]
  32. OKADA Y., YAMADA K., TADOKORO J. EFFECT OF ANTISERUM ON THE CELL FUSION REACTION CAUSED BY HVJ. Virology. 1964 Mar;22:397–409. doi: 10.1016/0042-6822(64)90030-3. [DOI] [PubMed] [Google Scholar]
  33. Orvell C., Norrby E. Immunologic properties of purified Sendai virus glycoproteins. J Immunol. 1977 Dec;119(6):1882–1887. [PubMed] [Google Scholar]
  34. PORTER R. R. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J. 1959 Sep;73:119–126. doi: 10.1042/bj0730119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. RAUH L. W., SCHMIDT R. MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC. Am J Dis Child. 1965 Mar;109:232–237. doi: 10.1001/archpedi.1965.02090020234007. [DOI] [PubMed] [Google Scholar]
  36. Scheid A., Caliguiri L. A., Compans R. W., Choppin P. W. Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology. 1972 Dec;50(3):640–652. doi: 10.1016/0042-6822(72)90418-7. [DOI] [PubMed] [Google Scholar]
  37. Scheid A., Choppin P. W. Protease activation mutants of sendai virus. Activation of biological properties by specific proteases. Virology. 1976 Jan;69(1):265–277. doi: 10.1016/0042-6822(76)90213-0. [DOI] [PubMed] [Google Scholar]
  38. Scheid A., Choppin P. W. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology. 1977 Jul 1;80(1):54–66. doi: 10.1016/0042-6822(77)90380-4. [DOI] [PubMed] [Google Scholar]
  39. Scott T. F., Bonanno D. E. Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine. N Engl J Med. 1967 Aug 3;277(5):248–250. doi: 10.1056/NEJM196708032770506. [DOI] [PubMed] [Google Scholar]
  40. Sobonya R. E., Hiller F. C., Pingleton W., Watanabe I. Fatal measles (rubeola) pneumonia in adults. Arch Pathol Lab Med. 1978 Jul;102(7):366–371. [PubMed] [Google Scholar]
  41. Tyrrell D. L., Norrby E. Structural polypeptides of measles virus. J Gen Virol. 1978 May;39(2):219–229. doi: 10.1099/0022-1317-39-2-219. [DOI] [PubMed] [Google Scholar]
  42. Vazquez J. J. Immunopathologic aspects of lung disease. Arch Intern Med. 1970 Sep;126(3):471–474. [PubMed] [Google Scholar]
  43. Vella P. P., Weibel R. E., Woodhour A. F., Mascoli C. C., Leagus M. B., Ittensohn O. L., Stokes J., Jr, Hilleman M. R. Respiratory virus vaccines. 8. Field evaluation of trivalent parainfluenza virus vaccine among preschool children in families, 1967-1968. Am Rev Respir Dis. 1969 Apr;99(4):526–541. doi: 10.1164/arrd.1969.99.4P1.526. [DOI] [PubMed] [Google Scholar]
  44. Wainberg M. A., Howe C. Antibody-mediated fusion of FL amnion cells infected with parainfluenza virus type 2. Immunol Commun. 1972;1(5):481–489. doi: 10.3109/08820137209022958. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES